NIMA-related kinase 2 overexpression is associated with poor survival in cancer patients: a systematic review and meta-analysis

References

• RenLLiuJGouKXingCCopy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysisJ Cancer20189122082209229937926
   PubMed Web of Science ®Google Scholar
• WangAWangSZhuCCoffee and cancer risk: a meta-analysis of prospective observational studiesSci Rep201663371127665923
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• WangYHuangYXiangPTianWLncRNA expression and implication in osteosaroma: a systematic review and meta-analysisOncoTargets Ther20171053555361
   PubMed Web of Science ®Google Scholar
• NaganoKHigashisakaKTsunodaSITsutsumiYDevelopment of a fundamental technology to seek drug targets, and its application to cancer targeting therapyYakugaku Zasshi2018138790390929962467
   PubMed Web of Science ®Google Scholar
• HaoMFranqui-MachinRXuHNEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myelomaLeukemia20173171648165028400617
   PubMed Web of Science ®Google Scholar
• HuangJSunSGHouSAberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanomaEur Rev Med Pharmacol Sci201822123694370229949142
   PubMed Web of Science ®Google Scholar
• FangYZhangXTargeting NEK2 as a promising therapeutic approach for cancer treatmentCell Cycle201615789590727019372
   PubMed Web of Science ®Google Scholar
• PrigentCGloverDMGietRDrosophila Nek2 protein kinase knockdown leads to centrosome maturation defects while overexpression causes centrosome fragmentation and cytokinesis failureExp Cell Res2005303111315572022
   PubMed Web of Science ®Google Scholar
• NaroCBarbagalloFChieffiPBourgeoisCFParonettoMPSetteCThe centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survivalNucleic Acids Res20144253218322724369428
   PubMed Web of Science ®Google Scholar
• LeeJGollahonLMitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cellsCell Cycle201312233599361424091727
   PubMed Web of Science ®Google Scholar
• Nuncia-CantareroMMartinez-CanalesSAndrés-PretelFSantpereGOcañaAGalan-MoyaEMFunctional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancerBreast Cancer Res Treat2018168361362329330624
   PubMed Web of Science ®Google Scholar
• ZhaoDHanWLiuXCuiDChenYMicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2Thorac Cancer20178430431128514100
   PubMed Web of Science ®Google Scholar
• TakahashiYIwayaTSawadaGUp-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancerAnn Surg Oncol201421120521224046120
   PubMed Web of Science ®Google Scholar
• KochMWieseMGene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancerJ Cancer Res Clin Oncol2013139225926723052694
   PubMed Web of Science ®Google Scholar
• KokuryoTSengaTYokoyamaYNek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma.NEK2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinomaCancer Res200767209637964217942892
   PubMed Web of Science ®Google Scholar
• ZengYRHanZDWangCOverexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancerBMC Urol201515909826320076
   PubMed Web of Science ®Google Scholar
• FuLLiuSWangHLow expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosisCancer Biomark201720110110628759960
   PubMed Web of Science ®Google Scholar
• NingZWangALiangJAbnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosisInt J Clin Exp Pathol2014752462246924966957
   PubMed Web of Science ®Google Scholar
• LiGZhongYShenQNEK2 serves as a prognostic biomarker for hepatocellular carcinomaInt J Oncol201750240541328101574
   PubMed Web of Science ®Google Scholar
• LiuHLiuBHouXOverexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant gliomaJ Neurooncol2017132340941728321704
   PubMed Web of Science ®Google Scholar
• ZhongXGuanXLiuWZhangLAberrant expression of NEK2 and its clinical significance in non-small cell lung cancerOncol Lett2014841470147625202351
   PubMed Web of Science ®Google Scholar
• TakahashiYIwayaTSawadaGUp-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancerAnn Surg Oncol201421120521224046120
   PubMed Web of Science ®Google Scholar
• ZhongXGuanXDongQYangSLiuWZhangLExamining Nek2 as a better proliferation marker in non-small cell lung cancer prognosisTumour Biol20143577155716224763826
   PubMedGoogle Scholar
• LuLZhaiXYuanRExamining Nek2 as a better proliferation marker in non-small cell lung cancer prognosisInt J Clin Exp Pathol20158154671547326823916
   PubMedGoogle Scholar
• WubetuGYMorineYTeraokuHHigh NEK2 expression is a predictor of tumor recurrence in hepatocellular carcinoma patients after hepatectomyAnticancer Res201636275776226851035
   PubMed Web of Science ®Google Scholar
• ShiYXYinJYShenYZhangWZhouHHLiuZQGenome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancerSci Rep201771807228808310
   PubMed Web of Science ®Google Scholar
• ZhangYWangWWangYNEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transitionOncol Rep20183931023103329399700
   PubMed Web of Science ®Google Scholar
• NealCPFryAMMoremanCOverexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survivalJ Surg Oncol2014110782883825043295
   PubMed Web of Science ®Google Scholar
• GuZXiaJXuHNEK2 promotes aerobic glycolysis in multiple myeloma through regulating splicing of pyruvate kinaseJ Hematol Oncol2017101172828086949
   PubMedGoogle Scholar
• MarinaMSaavedraHINek2 and PIk4: prognostic markers, drivers of breast tumorigenesis and drug resistanceFront Biosci (Landmark Ed)20141935236524389189
   PubMed Web of Science ®Google Scholar
• BarbagalloFParonettoMPFrancoRIncreased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomasJ Pathol2009217343144119023884
   PubMed Web of Science ®Google Scholar
• CappelloPBlaserHGorriniCRole of Nek2 on centrosome duplication and aneuploidy in breast cancer cellsOncogene201433182375238423708664
   PubMed Web of Science ®Google Scholar
• ChenCTianFLuLCharacterization of Cep85 - a new antagonist of Nek2A that is involved in the regulation of centrosome disjunctionJ Cell Sci2015128203837330326471995
   PubMed Web of Science ®Google Scholar
• Nuncia-CantareroMMartinez-CanalesSAndrés-PretelFSantpereGOcañaAGalan-MoyaEMFunctional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancerBreast Cancer Res Treat2018168361362329330624
   PubMed Web of Science ®Google Scholar
• WangJChengPPavlyukovMSTargeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2J Clin Invest201712783075308928737508
   PubMed Web of Science ®Google Scholar
• HaywardDGFryAMNek2 kinase in chromosome instability and cancerCancer Lett2006237215516616084011
   PubMed Web of Science ®Google Scholar
• ZhaoDHanWLiuXCuiDChenYDeguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2Thorac Cancer20178432032728509438
   PubMed Web of Science ®Google Scholar
• LaiXBNieYQHuangHLNIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferationOncol Lett20171331587159428454295
   PubMed Web of Science ®Google Scholar
• ZhangMXXuXMZhangPEffect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathwayTumour Biol20163722023203526337275
   PubMedGoogle Scholar
• TsunodaNKokuryoTOdaKNek2 as a novel molecular target for the treatment of breast carcinomaCancer Sci2009100111111619038001
   PubMed Web of Science ®Google Scholar
• ZhouWYangYXiaJNEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancersCancer Cell2013231486223328480
   PubMed Web of Science ®Google Scholar
• LiGZhongYShenQNEK2 serves as a prognostic biomarker for hepatocellular carcinomaInt J Oncol201750240541328101574
   PubMed Web of Science ®Google Scholar